Home Companies I wonder why CureVac N.V.'s (CVAC) stock fell in the pre-market session...

I wonder why CureVac N.V.’s (CVAC) stock fell in the pre-market session today?

Despite CureVac N.V.’s (CVAC) own lack of news, several stocks in the sector have been impacted due to a piece of larger market news, As the CureVac N.V, (CVAC) stock plunged -11.33% to $103.05 in the premarketing session today.

However, the company announced on December 14, 2020, that a pivotal Phase 2b/3 study of its mRNA vaccine candidate, CVnCoV, has enrolled its first participant against COVID-19. CVAC is developing transformative medicines based on messenger ribonucleic acid (mRNA).


The 2021 Backdoor Crypto Portfolio (free)

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.

Sponsored


Researchers at the randomized, observing blind, placebo-controlled Phase 2b/3 trial HERALD are planning to assess the safety and efficacy of CVnCoV at a dose of 12 g across Europe and Latin America.

There are also two primary efficacy objectives in addition to the primary safety objective: demonstrating the efficacy of CVnCoV in preventing COVID-19 cases of any severity in participants who have never been infected with the SARS-CoV-2.

There are also two primary efficacy objectives in addition to the primary safety objective: demonstrating the efficacy of CVnCoV in preventing COVID-19 cases of any severity in participants who have never been infected with the SARS-CoV-2.

Researchers will assess the effect of CVnCoV by analyzing symptomatic COVID-19 disease in a certain number of participants based on an event-driven analysis. As part of the participants’ continuous safety monitoring in the trials, the data will be reviewed regularly by an independent Data Safety Monitoring Board.

The extension study will collect additional data to assess and evaluate the durability of vaccine efficacy, the persistence of antibodies to SARS-CoV-2, and the occurrence of COVID-19 cases after completion of the trial.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Apple Inc. (AAPL) Stocks dip but future prospects for the company seem very positive

On Thursday, Apple shares (NASDAQ: AAPL) closed at $120.99 which is 3.5% lower. In the after-hours session, the price further declined by 0.2%.  The...

Tesla Inc. (TSLA): a Game of Thrones, Tweets and Bitcoin

Tesla Inc. (NASDAQ: TSLA) shares plunged by more than 8% when the market closed on Thursday. The news that most significantly impacted this plunge...

The Reasons Behind 30% Fall Of Tricida, Inc.’s (TCDA) Shares In Extended Trades

The drugmaker Tricida, Inc.’s (TCDA) shares experienced a fall of -29.62% in the trading after the ring of the bell on Thursday. The South...

Why Chromadex Corp. (CDXC) Remains A Gainer After Ring Of The Bell?

The biotechnology company ChromaDex Corporation (CDXC) continued the rally after ring of the bell on Thursday rising +18.68%. During the regular session price of...

ReTo Eco-Solutions Stock Drops Pre-Market Today: Why?

The manufacturer and distributor of construction material ReTo Eco-Solutions Inc. (NASDAQ: RETO) has been experiencing a fall of more than 10% in pre-market session...

What Took Gabelli Healthcare (GRX) Stock Down 18% In Pre-Market?

The Gabelli Healthcare & Wellness Trust (GRX) is sinking -18.33% in pre-market trading today following the announcement of a cash distribution by the organization...

What’s Hurting Tengasco Inc (TGC) Stock? Why Is It Down 26% Pre-Market?

Stock of oil and gas exploration firm Tengasco, Inc. (NYSE: TGC) is seeing a decline in pre-market trades today. Shares of the company were...

Apple Inc. (AAPL) Stocks dip but future prospects for the company seem very positive

On Thursday, Apple shares (NASDAQ: AAPL) closed at $120.99 which is 3.5% lower. In the after-hours session, the price further declined by 0.2%.  The...

Related News

When Buying Condor Hospitality Trust Inc. (AMEX:CDOR), you need to consider this metric

Condor Hospitality Trust, Inc. (NYSE: CDOR) is a real estate investment trust focused on owning mid-scale and upscale hotels with premium brands in the...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!...100% Free

We do not sell or share your information with anyone.

Get Best Morning Financial Newsletter... 100% Free

Best stocks ideas

Analysts’ Upgrades & Downgrades

Insider Watchlist

Important Earnings

We do not sell or share your information with anyone.